PHAXIAM Therapeutics S.A. / Fundamentals
Income statement
- Net revenue
€2.14M - Cost of goods sold
€469.00K - Gross profit
€1.67M - SG&A expenses
€9.92M - R&D expenses
€13.89M - EBITDA
-€17.69M - D&A
€411.50K - EBIT
-€21.92M - Interest expenses
€407.00K - EBT
-€21.90M - Tax expenses
-€723.00K - Net income
-€21.92M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€18.17M - Changes in working capital
-€2.33M - Operating cash flow
-€20.89M - Capex
€601.00K - Other investing cash flow
€9.00K - Net investing cash flow
-€477.00K - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
-€1.44M - Other financing cash flow
-€1.03M - Net financing cash flow
-€2.47M - Foreign exchange effects
€0.00 - Net change in cash
-€23.73M - Cash at end of period
€1.46M - Free cash flow
-€20.28M
Balance sheet
- Cash and cash equivalents
€1.46M - Cash and short-term investments
€1.46M - Total receivables
€3.35M - Inventory
€946.00K - Other current assets
€1.08M - Total current assets
€5.89M - Property, plant & equipment
€3.52M - Goodwill
€9.62M - Intangible assets
€19.79M - Long-term investments
€0.00 - Other non-current assets
€284.00K - Total non-current assets
€33.22M - Total assets
€39.11M - Accounts payable
€3.41M - Short-term debt
€5.67M - Other current liabilities
€6.42M - Total current liabilities
€15.51M - Long-term debt
€7.26M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€897.00K - Total non-current liabilities
€8.16M - Total liabilities
€23.66M - Common stock
€6.08M - Retained earnings
€0.00 - Other equity
-€29.95M - Total equity
€15.45M - Total liabilities and shareholders' equity
€39.11M
Company information
- Market capitalization
€19.90M - Employees
49 - Enterprise Value
€11.48M
Company ratios
- Gross margin
-
78.1% - EBITDA margin
-
-826.1% - EBIT margin
-
-1,023.8% - EBT margin
-
-1,022.9% - Net margin
-
-1,023.9% - ROE
-
-141.9% - ROA
-
-56.1% - Asset turnover
-
5.5% - FCF margin
-
-1,003.5% - FCF yield
-108.0% - Efficiency ratio
926.1% - Net sales per employee
-
€43.69K - Net income per employee
-
-€447.39K